Governor Signs Bill to Launch Ibogaine Clinical Trials – Magnolia Tribune
Ibogaine clinical trials legislation marks a significant step in addiction treatment research. This bill enables formal studies to evaluate ibogaine's efficacy and safety. It opens regulatory pathways for controlled psychedelic clinical trials.
The First Randomized Trial Of Cannabis For Migraine Relief – And What It Found
This randomized controlled trial cannabis migraine study provides preliminary evidence on cannabis for migraine relief. It is the first controlled trial addressing this treatment area. Clinicians now have emerging data to guide migraine patient care.
Study Details | NCT07498023 | Effects of a Full Spectrum Cannabis Extract
This page covers the full spectrum cannabis extract clinical trial NCT07498023, highlighting its high clinical relevance. The study registration provides early insights into emerging cannabis research. Clinicians should evaluate the study design and…
Emerging Cannabis-Related Colorectal Cancer Treatment Research
Cannabis-related colorectal cancer treatment is currently being tested in clinical trials in West Michigan. This emerging research focuses on potential therapeutic effects and symptom management. Clinicians await peer-reviewed data to evaluate its…
New Funding to Support SER-252 Trial in Advanced Parkinson’s
The synthetic cannabinoid Parkinsons trial SER-252 targets levodopa-induced dyskinesia in advanced Parkinson's disease. This novel therapeutic approach could improve management of motor symptoms. Ongoing research aims to validate its clinical efficacy…
CBD Shows Promise But Lacks Broad Regulatory Approval: A Sobering Review of the Evidence
The CBD pharmacology regulatory context reveals a narrow evidence base supporting broad approval. Most CBD products lack pharmaceutical-grade quality and regulatory endorsement. This 2024 review highlights the need for rigorous clinical trials and…
Mapping the Clinical Trial Landscape for Cannabinoids in Neurology: A Registry-Based Systematic Review
This systematic review of cannabinoid clinical trials neurological disorders highlights research focused on Multiple Sclerosis, Fibromyalgia, and Parkinson's Disease. It reveals challenges due to inconsistent protocols and dosing across studies. The…
CBD and Anxiety: Promising Signal, Weak Evidence Base
The cbd anxiety clinical trials 2024 review reveals most studies are exploratory with varied designs and small samples. Evidence supporting CBD for anxiety disorders remains weak and inconclusive. This review highlights the urgent need for robust…
Investigational Drugs in PTSD: Emerging Clinical Evidence
The endocannabinoid system and PTSD clinical evidence reveal promising investigational drugs targeting neurobiological pathways. PTSD remains challenging with limited FDA-approved options. Emerging treatments like ketamine and cannabinoids offer hope for…
Cannabis Research Institute | LinkedIn Overview
The cannabis research institute plays a vital role in advancing evidence-based cannabis medicine. These institutes provide expertise and resources for rigorous clinical trials. Their work supports the development of cannabinoid therapeutics and…